PCOS Risk Factors: What Raises Your Chances

Family History and Genetics: The Strongest Risk Signal

A family history of PCOS is among the clearest and most consistent risk factors identified in the research. If a first-degree relative — a mother or sister — has PCOS, personal risk is meaningfully elevated. Twin and family studies estimate the heritability of PCOS at approximately 70%, placing it among the more strongly heritable common endocrine conditions.

Genetic research has identified 15 PCOS-associated gene variants across 11 genetic regions, with several replicated across both Chinese and European populations. These variants point to genes involved in hormone production, insulin signalling, and androgen sensitivity — consistent with the condition's metabolic and hormonal profile.

What "genetic risk" means in practice is important to understand clearly. Carrying PCOS-associated gene variants does not guarantee the condition develops. PCOS typically emerges from genetic predisposition interacting with environmental or lifestyle factors — not from genetics alone. Women with a strong family history who have not yet developed symptoms are not certain to do so, but they have stronger grounds for early monitoring and proactive lifestyle habits.

[REVIEWER: add clinical insight here — e.g., how you counsel patients with a family history of PCOS who are asymptomatic, what monitoring schedule you recommend, and at what point you initiate investigations in a teenager with a positive family history]

Obesity and Weight: A Two-Way Relationship

Obesity is both a risk factor for PCOS and a frequent consequence of it — a relationship that is genuinely bidirectional and worth understanding in that way rather than as a simple cause-and-effect.

The connection may begin earlier than most people expect. One large study found that a higher genetic risk score for PCOS was associated with higher BMI and greater risk of obesity as early as mid-childhood, with the pattern persisting through adolescence. This suggests that the genetic underpinnings of PCOS may manifest as weight-related metabolic changes well before any reproductive symptoms appear — which has implications for who should be monitored and when.

Once PCOS develops, weight and the condition tend to reinforce each other. Obesity worsens insulin resistance, increases androgen production, and promotes systemic inflammation — all core features of PCOS. This is one reason weight management is positioned as a central component of PCOS treatment, not only prevention. Even modest weight loss of 5–10% of body weight has been shown to improve insulin sensitivity and menstrual regularity in women with overweight and PCOS.

Equally important: PCOS occurs in women at normal weight. Weight is a significant risk factor and modifier, but it is not a prerequisite for diagnosis. Lean women with PCOS tend to present with predominantly androgen-related symptoms and often face longer diagnostic delays precisely because the condition is incorrectly associated only with obesity.

Insulin Resistance and Diabetes History

Insulin resistance — and a personal or family history of type 2 diabetes — is a well-established PCOS risk factor. The relationship operates in both directions: insulin resistance contributes to PCOS development, and PCOS independently raises the long-term risk of type 2 diabetes, largely because chronically elevated insulin stimulates excess ovarian androgen production.

India's exceptionally high burden of insulin resistance and type 2 diabetes — with the ICMR estimating 101 million adults living with diabetes and a further 136 million with prediabetes as of 2023 — makes this risk factor particularly relevant in the Indian context. South Asian women develop insulin resistance at lower BMI thresholds than Western populations, which means PCOS-related metabolic risk may be present at body weights that would not raise concern using standard Western reference values.

Women with a family history of type 2 diabetes, prediabetes, or metabolic syndrome — even without obesity — have grounds for earlier and more proactive PCOS screening.

Other Contributing Factors

Beyond the three primary risk factors, several additional contributors appear in the research with varying degrees of evidence:

Diet and lifestyle: General dietary patterns and physical activity levels are cited as contributing risk factors. High intake of refined carbohydrates, added sugar, and ultra-processed foods — all of which worsen insulin resistance — are relevant to PCOS risk through the metabolic pathway described above.

Environmental pollutants: Exposure to endocrine-disrupting chemicals — including bisphenol A (BPA), phthalates, and certain pesticides — has been associated with PCOS risk in research, though this area is still developing and causation has not been firmly established in humans. It is an area of active investigation rather than settled science.

Gut microbiome imbalances: Disruptions in the composition of gut bacteria have been proposed as a contributing factor in PCOS, with some research suggesting differences in microbiome profiles between women with and without PCOS. This remains a developing area without firm clinical recommendations.

Smoking: Case-control studies have identified smoking as a risk factor for PCOS, likely through its effects on insulin resistance, androgen metabolism, and systemic inflammation. Smokeless tobacco — widely used in India — has not been separately studied to the same extent but shares relevant metabolic effects.

Related cardiometabolic risk: Women with PCOS who also have a family history of hypertension, type 2 diabetes, or impaired glucose tolerance carry higher risk of developing cardiovascular complications. PCOS-related risk factors do not stop at the diagnosis — they extend into long-term cardiometabolic health, which is why ongoing monitoring matters beyond managing immediate symptoms.

Does PCOS Risk Affect Male Relatives?

PCOS is only diagnosed in women, as diagnostic criteria depend on ovarian and menstrual symptoms. But genetic research raises a broader question about what the underlying risk means for male relatives. Studies have found that males with a family history of PCOS can show a poorer cardiometabolic profile — including higher rates of insulin resistance, dyslipidaemia, and early cardiovascular risk markers — suggesting that the genetic factors underlying PCOS may influence metabolic health across both sexes, even when the full condition cannot manifest.

This is primarily a research observation at this stage, but it reinforces the view that PCOS-associated genetics represent a broader metabolic vulnerability rather than a purely reproductive phenomenon.

Can PCOS Risk Be Reduced?

There is no guaranteed way to prevent PCOS, given the strength of genetic predisposition. What the evidence supports is that healthy lifestyle habits — a whole-food diet prioritising low-glycaemic foods, regular physical activity, adequate sleep, and limiting exposure to known environmental endocrine disruptors — may help reduce the risk of the condition developing or lessen its severity in those genetically predisposed.

These are the same habits that improve outcomes once PCOS is diagnosed. The practical value of knowing your risk factors is therefore not to generate anxiety, but to establish the lifestyle foundation and monitoring habits that are beneficial regardless of whether a diagnosis follows.

Who Should Talk to a Doctor About PCOS Risk?

Consider seeking evaluation if you have:

A mother or sister with PCOS
Irregular or absent periods, particularly alongside signs of elevated androgens (acne, excess facial or body hair, scalp hair thinning)
A personal history of insulin resistance, prediabetes, or type 2 diabetes — or a strong family history of these conditions
Significant weight gain concentrated around the abdomen, particularly in adolescence or early adulthood
Difficulty conceiving

There is no single blood test that confirms PCOS risk before symptoms appear. Doctors typically assess risk through family history, symptoms, and metabolic markers — fasting glucose, HbA1c, and fasting insulin — rather than genetic testing, which remains primarily a research tool. Early evaluation allows for lifestyle intervention during the window when it is most effective.

FAQ

Q: Is PCOS hereditary? Yes, significantly. Studies estimate PCOS heritability at approximately 70%, and having a mother or sister with the condition meaningfully increases personal risk. However, genetics alone do not determine whether PCOS develops — environmental factors, diet, weight, and insulin resistance all contribute. Many women with a strong family history never develop the condition.

Q: Does being overweight cause PCOS? Not directly, but obesity is a significant risk factor that worsens the condition once it develops. The relationship works in both directions: excess weight — particularly abdominal fat — drives insulin resistance and androgen excess, while PCOS itself makes weight management harder. Managing weight is one of the most evidence-backed approaches to reducing PCOS severity.

Q: Can normal-weight women develop PCOS? Yes. While obesity raises risk, PCOS occurs in women at normal or even low body weight, particularly when genetic or insulin-related factors are prominent. Lean women with PCOS are more likely to present with androgen-related symptoms such as acne or irregular periods. Weight is one risk factor among several, not a diagnostic requirement.

Q: At what age does PCOS risk begin? PCOS is typically diagnosed during the reproductive years, often first appearing around puberty. However, genetic risk factors can manifest earlier — research has identified weight and metabolic changes in childhood in girls with high genetic PCOS risk scores, before any reproductive symptoms appear. Adolescent girls with irregular periods and a family history of PCOS warrant early evaluation rather than a "wait and see" approach.

Q: Can PCOS risk factors be tested for before symptoms appear? There is no single predictive test. Doctors assess risk through family history, metabolic markers such as fasting insulin and glucose, and clinical signs such as acne or menstrual irregularity. Genetic testing for PCOS risk is a research tool, not a clinical standard. Metabolic screening — particularly for insulin resistance — is the most practically actionable assessment for women at elevated risk.